Globus Medical Balance Sheet Health
Financial Health criteria checks 5/6
Globus Medical has a total shareholder equity of $4.1B and total debt of $437.1M, which brings its debt-to-equity ratio to 10.7%. Its total assets and total liabilities are $5.1B and $1.0B respectively. Globus Medical's EBIT is $395.0M making its interest coverage ratio 52.1. It has cash and short-term investments of $694.7M.
Key information
10.7%
Debt to equity ratio
US$437.14m
Debt
| Interest coverage ratio | 52.1x |
| Cash | US$694.71m |
| Equity | US$4.07b |
| Total liabilities | US$1.02b |
| Total assets | US$5.09b |
Recent financial health updates
Globus Medical (NYSE:GMED) Has A Rock Solid Balance Sheet
Nov 04
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly
Mar 20Recent updates
Globus Medical Stock: Re-Rated After A Solid Year
Nov 18Globus Medical (NYSE:GMED) Has A Rock Solid Balance Sheet
Nov 04Globus Medical, Inc.'s (NYSE:GMED) Shareholders Might Be Looking For Exit
Oct 14Globus Medical: A Post Acquisition Analysis
Aug 26Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors
Jun 28An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued
Apr 08Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly
Mar 20Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock
Feb 27Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?
Feb 09Globus Medical: Merger Overhang Lingering
Nov 27Globus Medical: Almost Having My Back
Sep 13Globus Medical: Slightly Too Pricey Right Now
Aug 07Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy
Jul 18Globus Medical Q4 2022 Earnings Preview
Feb 20Globus Medical: An Impressive Long-Term Revenue Growth Play
Jan 08Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line
Nov 08Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact
Sep 02Financial Position Analysis
Short Term Liabilities: GMED's short term assets ($2.1B) exceed its short term liabilities ($818.1M).
Long Term Liabilities: GMED's short term assets ($2.1B) exceed its long term liabilities ($198.6M).
Debt to Equity History and Analysis
Debt Level: GMED has more cash than its total debt.
Reducing Debt: GMED's debt to equity ratio has increased from 0% to 10.7% over the past 5 years.
Debt Coverage: GMED's debt is well covered by operating cash flow (94.9%).
Interest Coverage: GMED's interest payments on its debt are well covered by EBIT (52.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 00:17 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Globus Medical, Inc. is covered by 27 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Matt Miksic | Barclays |
| Craig Bijou | BofA Global Research |